Wallington Asset Management’s AbbVie ABBV Stock Holding History

Wallington Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,655	Closed	-$378K	–	62
2025 Q4	$378K	Buy	1,655 +230	+16%	+$52.4K	0.05%	56
2025 Q3	$330K	Sell	1,425 -18	-1%	-$3.67K	0.04%	59
2025 Q2	$268K	Buy	1,443 +42	+3%	+$7.81K	0.04%	64
2025 Q1	$294K	Hold	1,401	–	–	0.04%	77
2024 Q4	$249K	Hold	1,401	–	–	0.04%	86
2024 Q3	$277K	Buy	+1,401	New	+$261K	0.04%	82
2015 Q1	–	Sell	-500	Closed	-$33K	–	59
2014 Q4	$33K	Sell	500 -100	-17%	-$6.3K	0.01%	78
2014 Q3	$35K	Buy	600 +100	+20%	+$5.55K	0.01%	75
2014 Q2	$28K	Hold	500	–	–	0.01%	76
2014 Q1	$26K	Hold	500	–	–	0.01%	84
2013 Q4	$26K	Hold	500	–	–	0.01%	71
2013 Q3	$22K	Hold	500	–	–	0.01%	73
2013 Q2	$21K	Buy	+500	New	+$21.9K	0.01%	73

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wallington Asset Management's ABBV Position: Q1 2026 in Review

Wallington Asset Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,655 shares — an estimated $378K sold.

Wallington Asset Management first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $378K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Wallington Asset Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Wallington Asset Management sold 1,655 AbbVie shares in Q1 2026, an estimated $378K.
Wallington Asset Management first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
Wallington Asset Management's AbbVie position peaked at $378K in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wallington Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.